The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
Monthly Archives: October, 2019
Scientists co-led by Sui Huang, MD, PhD, found an experimental drug called metarrestin significantly reduced metastasis and cancer progression in mouse models.
Considered the founding father of preventive cardiology, Jeremiah Stamler, MD, who celebrated his 100th birthday Oct. 27, is still conducting ‘brilliant science,’ according to his colleagues.
Ramael Ohiomoba, a second-year student, was one of two medical students in the country to be awarded the Dr. Richard Allen Williams Scholarship through the Association of Black Cardiologists.
A recent study found that the genetic distance between kidney donors and recipients could be used to more accurately predict transplant success.
Northwestern and Cell Press hosted a symposium on transcriptional regulation, welcoming more than 350 attendees from around the world.
Evangelos Kiskinis, PhD, has received a New York Stem Cell Foundation – Robertson Investigator Award to study the origins of ALS and pediatric epilepsy.
A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
Building on years of research and collaborations promoting optimal health and well-being among seniors, Feinberg has launched the Center for Applied Health Research on Aging.
David Cella, PhD, Susan Quaggin, MD, John Rogers, PhD, and Catherine Wolley, PhD, have been elected to the National Academy of Medicine, one of the highest honors in the field.